Inventor · disambiguated record
Renier J. Brentjens
Also filed as: BRENTJENS RENIER · BRENTJENS RENIER J
20 granted patents·23 pending applications·997 citations·filing 2003–2025
95Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER41JUNO THERAPEUTICS INC1SLOAN KETTERING INST CANCER1
Top patents by PatentIndex Score
43 records- 0198US7446190B2Nucleic acids encoding chimeric T cell receptorsSLOAN KETTERING INST CANCER·Filed 2003·Granted Nov 4, 2008·904 cites·13 claims
- 0297US11000549B2Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted May 11, 2021·6 cites·20 claims
- 0397US10906956B2Methods of treatments using chimeric antigen receptors targeting G-protein coupled receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Feb 2, 2021·7 cites·20 claims
- 0497US10821135B2Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Nov 3, 2020·7 cites·30 claims
- 0596US10918665B2Chimeric antigen receptors targeting B-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Feb 16, 2021·16 cites·57 claims
- 0695US11725059B2Antibodies targeting B-cell maturation antigen and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Aug 15, 2023·3 cites·40 claims
- 0794US10562972B2Antibodies targeting B-cell maturation antigen and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Feb 18, 2020·9 cites·67 claims
- 0893US10947314B2Antibodies targeting b-cell maturation antigen and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Mar 16, 2021·5 cites·30 claims
- 0991US10590196B2Antibodies targeting G-protein coupled receptor and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Mar 17, 2020·10 cites·46 claims
- 1091US10124023B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Nov 13, 2018·15 cites·15 claims
- 1188US10633426B2Chimeric antigen receptors targeting G-protein coupled receptor and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Apr 28, 2020·5 cites·49 claims
- 1286US2024335475A1Methods of using chimeric antigen receptors targeting b-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1385US11566071B2Nucleic acid molecules encoding anti-GPRC5D antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Jan 31, 2023·2 cites·35 claims
- 1485US10913796B2Antibodies targeting Fc receptor-like 5 and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Feb 9, 2021·2 cites·44 claims
- 1584US11866478B2Nucleic acid molecules encoding chimeric antigen receptors targeting G-protein coupled receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Jan 9, 2024·1 cites·40 claims
- 1684US11820806B2Chimeric antigen receptors targeting G-protein coupled receptor and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Nov 21, 2023·1 cites·50 claims
- 1784US2025059283A1Chimeric antigen receptors targeting fc receptor-like 5 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1884US2024294599A1Chimeric antigen receptors targeting g-protein coupled receptor and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1982US11059891B2Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 13, 2021·1 cites·63 claims
- 2080US11103531B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Aug 31, 2021·1 cites·19 claims
- 2179US2024076370A1Antibodies targeting g-protein coupled receptor and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2278US11136392B2PD-1 immune modulating agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Oct 5, 2021·1 cites·36 claims
- 2376US11766474B2IL-36 secreting immunoresponsive cells and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Sep 26, 2023·1 cites·24 claims
- 2474US2021346432A1Methods of using chimeric antigen receptors targeting b-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2572US12139538B2Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Nov 12, 2024·0 cites·31 claims
- 2669US2021369781A1Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2767US2024252640A1Antigen recognizing receptors targeting dll3 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2867US2024189426A1Chimeric receptors targeting muc16 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2966US2024307441A1Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 3066US2024042031A1Antigen recognizing receptors targeting gd3 ganglioside and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 3163US2023242879A1Il-33 secreting immunoresponsive cells and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 3262US2021388081A1Antibodies targeting fc receptor-like 5 and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3360US2024197879A1Antigen recognizing receptors targeting cd33 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 3459US2024262910A1Anti-cd33 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 3559US2022054550A1Combination therapiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3657US2025332256A1Antigen-recognizing receptors targeting b7-h3 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 3753US2023051064A1Chimeric antigen receptors with cd28 mutations and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3853US2022213211A1Antigen recognizing receptors targeting cd371 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3952US2022195064A1Anti-cd371 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 4051US2020399598A1Il-33 secreting immunoresponsive cells and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 4148US2019151363A1Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 4246US2021393689A1Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)JUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4346US2019099447A1Adoptive cell therapies as early treatment optionsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →